Atlas Venture Life Science Advisors, LLC - AVROBIO INC ownership

AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atlas Venture Life Science Advisors, LLC ownership history of AVROBIO INC
ValueSharesWeighting
Q3 2023$6,993,727
+62.1%
4,541,3810.0%1.08%
+101.7%
Q2 2023$4,314,766
-5.0%
4,541,3810.0%0.54%
-12.7%
Q1 2023$4,541,381
+40.9%
4,541,381
+0.5%
0.62%
+58.5%
Q4 2022$3,222,923
+10.9%
4,520,8630.0%0.39%
+20.9%
Q3 2022$2,905,000
-30.2%
4,520,8630.0%0.32%
-53.8%
Q2 2022$4,159,000
-30.3%
4,520,8630.0%0.70%
-7.9%
Q1 2022$5,968,000
-65.7%
4,520,8630.0%0.76%
-52.8%
Q4 2021$17,405,0004,520,8631.60%
Other shareholders
AVROBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,191,676$16,612,0008.00%
Aisling Capital Management LP 1,009,779$14,076,0002.42%
Burrage Capital Management LLC 145,715$2,031,0001.55%
Camber Capital Management LP 3,133,333$43,679,0001.53%
New Leaf Venture Partners, L.L.C. 315,550$4,399,0001.02%
SPHERA FUNDS MANAGEMENT LTD. 655,874$9,143,0000.81%
EMERALD ADVISERS, LLC 1,009,212$14,068,0000.47%
Penn Mutual Asset Management, LLC 37,306$520,0000.46%
EMERALD MUTUAL FUND ADVISERS TRUST 932,627$13,001,0000.45%
MPM BioImpact LLC 364,285$5,078,0000.44%
View complete list of AVROBIO INC shareholders